Table 1 Baseline characteristics of participants stratified by the inflammation score

Male (%)

30 (66.7)

18 (54.5)

31 (75.6)

62 (66.0)

Age (y)

52.8 ± 14.9

58.2 ± 11.9

57.3 ± 16.7

58.0 ± 13.8

Body mass index (kg/m²)

22.8 ± 3.5

23.1 ± 3.7

22.8 ± 3.3

23.2 ± 3.4

Diabetes (%)

12 (26.7)

12 (36.4)

10 (24.4)

36 (38.3%)

24 h urine output (mL)

650 (350–1075)

850 (550–1275)

525 (300–750)

725 (400–1035)

Systolic pressure (mmHg)

165 ± 28

162 ± 29

165 ± 26

162 ± 29

Diastolic pressure (mmHg)

96 ± 19

93 ± 19

96 ± 16

96 ± 18

Mean arterial pressure (mmHg)

119 ± 20

116 ± 21

119 ± 18

118 ± 21

NLR

3.05 (2.37–3.66)

3.71 (3.11–4.52)

5.92 (4.91–8.40)

10.73 (7.18–16.15)

MLR

0.29 (0.22–0.33)

0.40 (0.34–0.51)

0.46 (0.38–0.65)

0.67 (0.50–0.93)

PLR

124 (86–147)

165 (119–197)

194 (156–262)

286 (236–391)

Hemoglobin (g/L)

77.9 ± 19.5

84.3 ± 14.6

81.9 ± 20.6

80.1 ± 22.1

Albumin (g/L)

33.7 ± 8.2

36.5 ± 5.7

34.2 ± 6.3

35.3 ± 5.8

Blood urea nitrogen (mmol/L)

28.1 ± 10.3

28.1 ± 10.7

30.3 ± 14.2

33.8 ± 13.3

Serum creatinine (µmol/L)

801 (643–1273)

825 (667–1187)

847 (651–1102)

856 (656–1202)

Serum uric acid (µmol/L)

512 ± 142

526 ± 139

529 ± 144

548 ± 170

Calcium (mmol/L)

1.91 ± 0.28

1.97 ± 0.29

1.87 ± 0.31

1.91 ± 0.30

Phosphorus (mmol/L)

1.82 ± 0.68

1.80 ± 0.63

1.84 ± 0.70

1.90 ± 0.75

iPTH (pg/mL)

161 (87–292)

186 (115–382)

255 (163–411)

248 (97–414)

CRP (mg/L)

1.60 (0.00-5.15)

3.30 (0.10–9.65)

7.90 (3.00-31.65)

18.80 (2.00–46.00)

ALT (U/L)

17 (11–24)

15 (10–19)

19 (12–26)

16 (9–22)

Total bilirubin (mmol/L)

4.40 (2.93–6.93)

5.40 (3.15–6.75)

4.90 (3.85–7.95)

4.90 (3.10–6.60)

Total cholesterol (mmol/L)

5.06 ± 1.89

4.53 ± 1.39

4.65 ± 1.48

4.40 ± 1.17

Triglyceride (mmol/L)

1.33 (0.95–2.01)

1.53 (0.98–2.36)

1.17 (0.99–1.63)

1.22 (0.89–1.86)

LDL-C (mmol/L)

2.86 ± 1.71

2.61 ± 1.18

2.67 ± 1.06

2.28 ± 0.83

HDL-C (mmol/L)

1.27 ± 0.31

1.18 ± 0.39

1.27 ± 0.40

1.20 ± 0.46